Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
Pediatr Rheumatol Online J. 2021 Jun 2;19(1):78. doi: 10.1186/s12969-021-00566-6.
This study aimed to assess the occurrence of coronary artery lesions (CAL) in patients with Kawasaki disease (KD) according to serum C-reactive protein (CRP) levels.
This retrospective analysis was based on the nationwide survey of KD conducted in the Republic of Korea between 2015 and 2017. We enrolled 9131 patients and defined low (< 3 mg/dL) and high (≥3 mg/dL) CRP groups. Demographic data, clinical characteristics, z-scores, and scores based on the Japanese criteria for CAL were compared between the two groups. Logistic regression analysis was used to identify CAL risk factors.
The low CRP group accounted for 23% of patients. The mean age at diagnosis was higher in high CRP group compared to the low CRP group (34.4 ± 24.9 vs 31.7 ± 24.8 months, p < 0.001). Fever duration before treatment was not significantly different between the two groups (5.1 ± 1.7 days vs. 5.2 ± 2.1 days; p = 0.206). A non-response to intravenous immunoglobulin treatment was found in 1377 patients (20.1%) and 225 patients (11.7%) in the high and low CRP groups, respectively (p < 0.001). CAL were found in 12.9 and 18.3% of the high and low CRP patients, respectively (p < 0.001), based on z-scores; and in 9.9 and 12.5%, respectively (p = 0.001), based on the Japanese criteria in the acute phase. The giant coronary artery aneurysm occurrence ratio was similar between groups (p = 1.0).
CAL occurred in patients with both high and low CRP. Therefore, patients with KD should be carefully monitored regardless of their CRP levels.
本研究旨在根据血清 C 反应蛋白(CRP)水平评估川崎病(KD)患者冠状动脉病变(CAL)的发生情况。
本回顾性分析基于 2015 年至 2017 年在韩国进行的全国性 KD 调查。共纳入 9131 例患者,将 CRP 水平分为低(<3mg/dL)和高(≥3mg/dL)两组。比较两组患者的人口统计学数据、临床特征、Z 评分和基于日本 CAL 标准的评分。采用 Logistic 回归分析确定 CAL 的危险因素。
低 CRP 组占患者的 23%。与低 CRP 组相比,高 CRP 组患者的诊断时年龄更高(34.4±24.9 个月 vs 31.7±24.8 个月,p<0.001)。两组患者治疗前发热时间无显著差异(5.1±1.7 天 vs. 5.2±2.1 天;p=0.206)。高 CRP 组和低 CRP 组分别有 1377 例(20.1%)和 225 例(11.7%)患者对静脉注射免疫球蛋白治疗无反应(p<0.001)。根据 Z 评分,高 CRP 组和低 CRP 组的 CAL 发生率分别为 12.9%和 18.3%(p<0.001);根据急性期日本标准,分别为 9.9%和 12.5%(p=0.001)。两组巨型冠状动脉瘤发生率相似(p=1.0)。
高 CRP 和低 CRP 的 KD 患者均会发生 CAL。因此,无论 CRP 水平如何,均应密切监测 KD 患者。